Have the utmost confidence in products you use
Nobel Biocare impresses at The Dentistry Show 2015
Demonstrating how it remains at the forefront of innovation in implant dentistry, Nobel Biocare unveiled exciting new solutions at this year’s Dentistry Show.
Leading the way for successful implant placement and restoration in the posterior zone, Nobel Biocare launched the impressive Complete Posterior Solution to the UK.
Designed specifically to deliver the increased stability required for implants in the posterior region, the solution consists of:
- NobelActiveÒ Wide Platform (WP) implant
- NobelParallelÒ Conical Connection implant system
- Angulated Screw Channel (ASC) abutment and Omnigrip tooling
- PEEK healing and temporary abutment
- NobelProceraÒ Full Contour Zirconia (FCZ) Implant Crown.
Effective as stand alone products, these solutions integrate seamlessly for even better results when used together.
Another highlight for visitors to Nobel Biocare’s stand was the creosTM xenoprotect collagen membrane, which offers exceptional handling properties and high mechanical strength[1] for successful soft tissue and bone regeneration procedures.
With such innovative products at your disposal, you and your patients can have confidence in the procedures you perform. Find out more about the solutions from Nobel Biocare and contact the team today.
For more information, contact Nobel Biocare on 0208 756 3300 or visit www.nobelbiocare.com
[1] Bozkurt A, Apel C, Sellhaus B, van Neerven S, Wessing B, Hilgers R-D, Pallua N. Differences in degradation behavior of two non-cross-linked collagen barrier membranes: an in vitro and in vivo study. Clin. Oral Impl. Res. 00, 2013, 1-9 doi: 10.1111/clr.12284 [Epub ahead of print]*
* Since 2013 the Remaix™ membrane (Matricel GmbH, Germany) has been marketed as creos xenoprotect by Nobel Biocare.
About the author
Related Posts
Comments
By accepting you will be accessing a service provided by a third-party external to https://www.gdpuk.com/
GDPUK Ltd announces sale of intellectual property to leading publisher Cogora Group
GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands, events and educational platforms.
The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website.
“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”
Tony will continue involvement in GDPUK on a consulting basis.
GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.